Literature DB >> 30616037

Photobiological properties of phthalocyanine photosensitizers Photosens, Holosens and Phthalosens: A comparative in vitro analysis.

Anna A Brilkina1, Lubov V Dubasova1, Ekaterina A Sergeeva2, Anton J Pospelov1, Natalia Y Shilyagina1, Natalia M Shakhova2, Irina V Balalaeva3.   

Abstract

Photobiological properties of phthalocyanine photosensitizers, namely, clinically approved Photosens and new compounds Holosens and Phthalosens were analyzed on transitional cell carcinoma of the urinary bladder (T24) and human hepatic adenocarcinoma (SK-HEP-1). Photosens is a sulfated aluminum phthalocyanine with the number of sulfo groups 3.4, which is characterized by a high degree of hydrophilicity, slow cellular uptake, localization in lysosomes and the lowest photodynamic activity. Holosens is an octacholine zinc phthalocyanine, a cationic compound with significant charge. Holosens more efficiently enters the cells; it is localized in Golgi apparatus in addition to lysosomes and exhibits a significant inhibitory effect on cell viability upon irradiation. The highest photodynamic activity was demostrated by Phthalosens. Phthalosens is a metal-free analog of Photosens with a number of sulfo groups 2.5, which determines its amphiphilicity. Phthalosens is characterized by the highest rate of cellular uptake through the outer cell membrane, localization in cell membrane as well as in lysosomes and Golgi apparatus, and the highest activity upon irradiation among the photosensitizers studied. In general, changes in the physicochemical properties of Holosens and Phthalosens ensured an increase in their efficiency in vitro compared to Photosens. The features of accumulation, intracellular distribution and their interrelation with photodynamic activity, revealed in this work, indicate the prospects of Phthalosens and Holosens for clinical practice.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dark toxicity; Holosens; Intracellular distribution; Photodynamic activity; Photodynamic treatment; Photosens; Phthalocyanines; Phthalosens

Mesh:

Substances:

Year:  2018        PMID: 30616037     DOI: 10.1016/j.jphotobiol.2018.12.020

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  11 in total

Review 1.  Critical discussion of the applications of metal complexes for 2-photon photodynamic therapy.

Authors:  Johannes Karges; Hui Chao; Gilles Gasser
Journal:  J Biol Inorg Chem       Date:  2020-11-04       Impact factor: 3.358

Review 2.  Advantages of combined photodynamic therapy in the treatment of oncological diseases.

Authors:  Mikhail Grin; Nikita Suvorov; Petr Ostroverkhov; Viktor Pogorilyy; Nikita Kirin; Alexander Popov; Anna Sazonova; Elena Filonenko
Journal:  Biophys Rev       Date:  2022-06-09

Review 3.  Microbubbles Stabilized by Protein Shell: From Pioneering Ultrasound Contrast Agents to Advanced Theranostic Systems.

Authors:  Polina G Rudakovskaya; Roman A Barmin; Pavel S Kuzmin; Elena P Fedotkina; Alexander N Sencha; Dmitry A Gorin
Journal:  Pharmaceutics       Date:  2022-06-10       Impact factor: 6.525

Review 4.  Photodynamic Therapy for Cancer: What's Past is Prologue.

Authors:  Michael R Hamblin
Journal:  Photochem Photobiol       Date:  2020-01-07       Impact factor: 3.421

5.  Peripherally Crowded Cationic Phthalocyanines as Efficient Photosensitizers for Photodynamic Therapy.

Authors:  Marie Halaskova; Asma Rahali; Verónica Almeida-Marrero; Miloslav Machacek; Radim Kucera; Bassem Jamoussi; Tomás Torres; Veronika Novakova; Andrés de la Escosura; Petr Zimcik
Journal:  ACS Med Chem Lett       Date:  2021-03-01       Impact factor: 4.345

6.  Model of Ovarian Adenocarcinoma Spheroids for Assessing Photodynamic Cytotoxicity.

Authors:  E A Sokolova; A O Senatskaya; S A Lermontova; E K Akinchits; L G Klapshina; A A Brilkina; I V Balalaeva
Journal:  Sovrem Tekhnologii Med       Date:  2020

7.  Immunogenic cell death induced by a new photodynamic therapy based on photosens and photodithazine.

Authors:  Victoria D Turubanova; Irina V Balalaeva; Tatiana A Mishchenko; Elena Catanzaro; Razan Alzeibak; Nina N Peskova; Iuliia Efimova; Claus Bachert; Elena V Mitroshina; Olga Krysko; Maria V Vedunova; Dmitri V Krysko
Journal:  J Immunother Cancer       Date:  2019-12-16       Impact factor: 13.751

8.  Air-Filled Bubbles Stabilized by Gold Nanoparticle/Photodynamic Dye Hybrid Structures for Theranostics.

Authors:  Roman A Barmin; Polina G Rudakovskaya; Olga I Gusliakova; Olga A Sindeeva; Ekaterina S Prikhozhdenko; Elizaveta A Maksimova; Ekaterina N Obukhova; Vasiliy S Chernyshev; Boris N Khlebtsov; Alexander A Solovev; Gleb B Sukhorukov; Dmitry A Gorin
Journal:  Nanomaterials (Basel)       Date:  2021-02-06       Impact factor: 5.076

Review 9.  EGFR-Targeted Photodynamic Therapy.

Authors:  Luca Ulfo; Paolo Emidio Costantini; Matteo Di Giosia; Alberto Danielli; Matteo Calvaresi
Journal:  Pharmaceutics       Date:  2022-01-20       Impact factor: 6.321

10.  Nanoscale Metal-Organic Framework Confines Zinc-Phthalocyanine Photosensitizers for Enhanced Photodynamic Therapy.

Authors:  Taokun Luo; Geoffrey T Nash; Ziwan Xu; Xiaomin Jiang; Jianqiao Liu; Wenbin Lin
Journal:  J Am Chem Soc       Date:  2021-08-23       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.